CRL Annual CAPEX
$318.53 M
-$6.21 M-1.91%
30 December 2023
Summary:
As of January 19, 2025, CRL annual capital expenditures is $318.53 million, with the most recent change of -$6.21 million (-1.91%) on December 30, 2023. During the last 3 years, it has risen by +$151.97 million (+91.24%). CRL annual CAPEX is now -1.91% below its all-time high of $324.73 million, reached on December 31, 2022.CRL CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly CAPEX
$38.72 M
-$765.00 K-1.94%
28 September 2024
Summary:
As of January 19, 2025, CRL quarterly capital expenditures is $38.72 million, with the most recent change of -$765.00 thousand (-1.94%) on September 28, 2024. Over the past year, it has dropped by -$39.60 million (-50.56%). CRL quarterly CAPEX is now -63.77% below its all-time high of $106.88 million, reached on March 1, 2023.CRL Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL TTM CAPEX
$235.67 M
-$27.23 M-10.36%
28 September 2024
Summary:
As of January 19, 2025, CRL TTM capital expenditures is $235.67 million, with the most recent change of -$27.23 million (-10.36%) on September 28, 2024. Over the past year, it has dropped by -$82.85 million (-26.01%). CRL TTM CAPEX is now -32.88% below its all-time high of $351.14 million, reached on March 1, 2023.CRL TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -1.9% | -50.6% | -26.0% |
3 y3 years | +91.2% | -50.6% | -26.0% |
5 y5 years | +127.4% | -50.6% | -26.0% |
CRL CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -1.9% | +39.2% | -63.8% | at low | -32.9% | +3.0% |
5 y | 5-year | -1.9% | +126.7% | -63.8% | +50.5% | -32.9% | +67.7% |
alltime | all time | -1.9% | +2574.7% | -63.8% | +1498.7% | -32.9% | +8359.2% |
Charles River Laboratories International CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $38.72 M(-1.9%) | $235.67 M(-10.4%) |
June 2024 | - | $39.49 M(-50.1%) | $262.90 M(-9.6%) |
Mar 2024 | - | $79.14 M(+1.0%) | $290.80 M(-8.7%) |
Dec 2023 | $318.53 M(-1.9%) | $78.32 M(+18.8%) | $318.53 M(-3.3%) |
Sept 2023 | - | $65.95 M(-2.1%) | $329.23 M(-1.9%) |
June 2023 | - | $67.38 M(-37.0%) | $335.68 M(-4.4%) |
Mar 2023 | - | $106.88 M(+20.1%) | $351.14 M(+8.1%) |
Dec 2022 | $324.73 M(+41.9%) | $89.02 M(+23.0%) | $324.73 M(-2.9%) |
Sept 2022 | - | $72.39 M(-12.6%) | $334.48 M(+5.3%) |
June 2022 | - | $82.85 M(+3.0%) | $317.63 M(+13.0%) |
Mar 2022 | - | $80.46 M(-18.5%) | $281.21 M(+22.9%) |
Dec 2021 | $228.77 M(+37.4%) | $98.78 M(+77.9%) | $228.77 M(+5.0%) |
Sept 2021 | - | $55.54 M(+19.6%) | $217.85 M(+15.6%) |
June 2021 | - | $46.43 M(+65.6%) | $188.50 M(+11.6%) |
Mar 2021 | - | $28.03 M(-68.1%) | $168.87 M(+1.4%) |
Dec 2020 | $166.56 M(+18.5%) | $87.85 M(+235.5%) | $166.56 M(+16.8%) |
Sept 2020 | - | $26.18 M(-2.3%) | $142.54 M(-5.9%) |
June 2020 | - | $26.80 M(+4.2%) | $151.52 M(+1.4%) |
Mar 2020 | - | $25.72 M(-59.7%) | $149.50 M(+6.4%) |
Dec 2019 | $140.51 M(+0.3%) | $63.84 M(+81.6%) | $140.51 M(-3.3%) |
Sept 2019 | - | $35.16 M(+41.9%) | $145.35 M(+9.6%) |
June 2019 | - | $24.78 M(+48.1%) | $132.63 M(+2.8%) |
Mar 2019 | - | $16.73 M(-75.6%) | $129.06 M(-7.9%) |
Dec 2018 | $140.05 M(+69.9%) | $68.68 M(+206.1%) | $140.05 M(+40.2%) |
Sept 2018 | - | $22.44 M(+5.8%) | $99.88 M(+0.4%) |
June 2018 | - | $21.21 M(-23.5%) | $99.45 M(+5.5%) |
Mar 2018 | - | $27.73 M(-2.7%) | $94.24 M(+14.3%) |
Dec 2017 | $82.43 M(+49.1%) | $28.50 M(+29.5%) | $82.43 M(+3.5%) |
Sept 2017 | - | $22.01 M(+37.6%) | $79.61 M(+18.5%) |
June 2017 | - | $16.00 M(+0.5%) | $67.16 M(+6.7%) |
Mar 2017 | - | $15.92 M(-38.0%) | $62.96 M(+13.9%) |
Dec 2016 | $55.29 M(-12.6%) | $25.68 M(+168.4%) | $55.29 M(-4.4%) |
Sept 2016 | - | $9.57 M(-18.9%) | $57.85 M(-1.5%) |
June 2016 | - | $11.79 M(+42.9%) | $58.74 M(-3.5%) |
Mar 2016 | - | $8.25 M(-70.8%) | $60.85 M(-3.8%) |
Dec 2015 | $63.25 M(+11.1%) | $28.24 M(+170.2%) | $63.25 M(+2.0%) |
Sept 2015 | - | $10.45 M(-24.8%) | $62.03 M(+1.7%) |
June 2015 | - | $13.91 M(+30.6%) | $60.98 M(+8.1%) |
Mar 2015 | - | $10.65 M(-60.6%) | $56.38 M(-1.0%) |
Dec 2014 | $56.92 M(+45.4%) | $27.02 M(+187.4%) | $56.92 M(+30.1%) |
Sept 2014 | - | $9.40 M(+0.9%) | $43.74 M(+0.7%) |
June 2014 | - | $9.31 M(-16.8%) | $43.44 M(-1.1%) |
Mar 2014 | - | $11.19 M(-19.1%) | $43.91 M(+12.2%) |
Dec 2013 | $39.15 M(-17.6%) | $13.84 M(+52.1%) | $39.15 M(+0.2%) |
Sept 2013 | - | $9.10 M(-7.1%) | $39.06 M(-2.9%) |
June 2013 | - | $9.79 M(+52.3%) | $40.20 M(+0.9%) |
Mar 2013 | - | $6.43 M(-53.2%) | $39.85 M(-16.2%) |
Dec 2012 | $47.53 M | $13.74 M(+34.1%) | $47.53 M(-22.4%) |
Sept 2012 | - | $10.24 M(+8.5%) | $61.27 M(+3.4%) |
June 2012 | - | $9.44 M(-33.1%) | $59.25 M(+4.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2012 | - | $14.11 M(-48.6%) | $56.47 M(+14.9%) |
Dec 2011 | $49.14 M(+14.7%) | $27.47 M(+234.1%) | $49.14 M(+30.4%) |
Sept 2011 | - | $8.22 M(+23.4%) | $37.68 M(-2.3%) |
June 2011 | - | $6.66 M(-1.9%) | $38.59 M(-4.4%) |
Mar 2011 | - | $6.79 M(-57.6%) | $40.36 M(-5.8%) |
Dec 2010 | $42.86 M(-46.3%) | $16.01 M(+75.4%) | $42.86 M(-0.7%) |
Sept 2010 | - | $9.13 M(+8.3%) | $43.18 M(-17.8%) |
June 2010 | - | $8.43 M(-9.3%) | $52.52 M(-18.6%) |
Mar 2010 | - | $9.29 M(-43.1%) | $64.52 M(-19.2%) |
Dec 2009 | $79.85 M(-59.5%) | $16.33 M(-11.6%) | $79.85 M(-26.3%) |
Sept 2009 | - | $18.46 M(-9.6%) | $108.38 M(-20.6%) |
June 2009 | - | $20.44 M(-17.0%) | $136.56 M(-24.6%) |
Mar 2009 | - | $24.63 M(-45.1%) | $181.08 M(-8.1%) |
Dec 2008 | $197.08 M(-13.2%) | $44.85 M(-3.8%) | $197.08 M(-18.4%) |
Sept 2008 | - | $46.64 M(-28.2%) | $241.59 M(-1.5%) |
June 2008 | - | $64.95 M(+59.9%) | $245.28 M(+6.8%) |
Mar 2008 | - | $40.63 M(-54.5%) | $229.74 M(+1.2%) |
Dec 2007 | $227.04 M(+24.9%) | $89.36 M(+77.5%) | $227.04 M(+3.4%) |
Sept 2007 | - | $50.34 M(+1.9%) | $219.66 M(+3.5%) |
June 2007 | - | $49.41 M(+30.3%) | $212.29 M(+17.8%) |
Mar 2007 | - | $37.92 M(-53.7%) | $180.28 M(-0.8%) |
Dec 2006 | $181.75 M(+92.3%) | $81.99 M(+90.8%) | $181.75 M(+46.2%) |
Sept 2006 | - | $42.97 M(+146.9%) | $124.33 M(-2.5%) |
June 2006 | - | $17.40 M(-55.8%) | $127.55 M(+5.0%) |
Mar 2006 | - | $39.39 M(+60.3%) | $121.51 M(+28.6%) |
Dec 2005 | $94.52 M(+111.3%) | $24.57 M(-46.8%) | $94.52 M(+2.1%) |
Sept 2005 | - | $46.19 M(+306.6%) | $92.58 M(+63.5%) |
June 2005 | - | $11.36 M(-8.4%) | $56.63 M(+7.6%) |
Mar 2005 | - | $12.40 M(-45.2%) | $52.61 M(+17.6%) |
Dec 2004 | $44.73 M(+36.8%) | $22.62 M(+120.9%) | $44.73 M(+27.6%) |
Sept 2004 | - | $10.24 M(+39.5%) | $35.05 M(+16.4%) |
June 2004 | - | $7.34 M(+62.3%) | $30.12 M(-5.9%) |
Mar 2004 | - | $4.53 M(-65.0%) | $31.99 M(-2.2%) |
Dec 2003 | $32.70 M(-12.9%) | $12.94 M(+143.4%) | $32.70 M(-8.4%) |
Sept 2003 | - | $5.32 M(-42.3%) | $35.70 M(-5.3%) |
June 2003 | - | $9.22 M(+76.1%) | $37.69 M(-1.4%) |
Mar 2003 | - | $5.24 M(-67.1%) | $38.24 M(+1.9%) |
Dec 2002 | $37.54 M(+2.4%) | $15.93 M(+118.0%) | $37.54 M(-0.5%) |
Sept 2002 | - | $7.31 M(-25.2%) | $37.74 M(-3.8%) |
June 2002 | - | $9.77 M(+115.5%) | $39.24 M(+6.2%) |
Mar 2002 | - | $4.54 M(-71.9%) | $36.94 M(+0.8%) |
Dec 2001 | $36.66 M(+135.5%) | $16.13 M(+83.2%) | $36.66 M(+33.0%) |
Sept 2001 | - | $8.80 M(+17.8%) | $27.57 M(+30.1%) |
June 2001 | - | $7.47 M(+75.7%) | $21.18 M(+24.4%) |
Mar 2001 | - | $4.25 M(-39.6%) | $17.03 M(+9.4%) |
Dec 2000 | $15.56 M(+20.2%) | $7.04 M(+190.5%) | $15.56 M(+82.5%) |
Sept 2000 | - | $2.42 M(-27.1%) | $8.53 M(+39.7%) |
June 2000 | - | $3.32 M(+19.2%) | $6.11 M(+119.2%) |
Mar 2000 | - | $2.79 M | $2.79 M |
Dec 1999 | $12.95 M(+8.7%) | - | - |
Dec 1998 | $11.91 M | - | - |
FAQ
- What is Charles River Laboratories International annual capital expenditures?
- What is the all time high annual CAPEX for Charles River Laboratories International?
- What is Charles River Laboratories International annual CAPEX year-on-year change?
- What is Charles River Laboratories International quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly CAPEX year-on-year change?
- What is Charles River Laboratories International TTM capital expenditures?
- What is the all time high TTM CAPEX for Charles River Laboratories International?
- What is Charles River Laboratories International TTM CAPEX year-on-year change?
What is Charles River Laboratories International annual capital expenditures?
The current annual CAPEX of CRL is $318.53 M
What is the all time high annual CAPEX for Charles River Laboratories International?
Charles River Laboratories International all-time high annual capital expenditures is $324.73 M
What is Charles River Laboratories International annual CAPEX year-on-year change?
Over the past year, CRL annual capital expenditures has changed by -$6.21 M (-1.91%)
What is Charles River Laboratories International quarterly capital expenditures?
The current quarterly CAPEX of CRL is $38.72 M
What is the all time high quarterly CAPEX for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly capital expenditures is $106.88 M
What is Charles River Laboratories International quarterly CAPEX year-on-year change?
Over the past year, CRL quarterly capital expenditures has changed by -$39.60 M (-50.56%)
What is Charles River Laboratories International TTM capital expenditures?
The current TTM CAPEX of CRL is $235.67 M
What is the all time high TTM CAPEX for Charles River Laboratories International?
Charles River Laboratories International all-time high TTM capital expenditures is $351.14 M
What is Charles River Laboratories International TTM CAPEX year-on-year change?
Over the past year, CRL TTM capital expenditures has changed by -$82.85 M (-26.01%)